BlackRock Investment Management’s Kyntra Bio KYNB Stock Holding History

BlackRock Investment Management’s Portfolio KYNB Stock Details KYNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$4.16M	Sell	7,775 -33	-0.4%	-$16.5K	﹤0.01%	1715
2016 Q3	$4.04M	Buy	7,808 +11	+0.1%	+$5.18K	0.01%	1632
2016 Q2	$3.2M	Buy	7,797 +1,113	+17%	+$510K	﹤0.01%	1760
2016 Q1	$3.56M	Buy	6,684 +262	+4%	+$131K	﹤0.01%	1604
2015 Q4	$4.89M	Buy	6,422 +22	+0.3%	+$14.6K	0.01%	1403
2015 Q3	$3.51M	Sell	6,400 -67	-1%	-$40.6K	﹤0.01%	1630
2015 Q2	$3.8M	Buy	6,467 +5,434	+526%	+$3.16M	﹤0.01%	1718
2015 Q1	$810K	Buy	1,033 +21	+2%	+$16.3K	﹤0.01%	2658
2014 Q4	$692K	Buy	+1,012	New	+$651K	﹤0.01%	2809

Other funds holding KYNB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

HIM

Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

BlackRock Investment Management's KYNB Position: Q4 2016 in Review

BlackRock Investment Management reduced its Kyntra Bio (KYNB) stake by 0.42% in Q4 2016, selling an estimated $16.5K and leaving 7,775 shares worth $4.16M. The position accounts for ﹤0.01% of the portfolio, ranked #1715.

BlackRock Investment Management first reported a position in KYNB in Q4 2014 and has held it in 9 quarters since. The position peaked at $4.89M in Q4 2015. 140 funds tracked by Wall St. Rank hold KYNB as of Q4 2016.

BlackRock Investment Management held 7,775 shares of Kyntra Bio worth $4.16M as of Q4 2016.
BlackRock Investment Management sold 33 Kyntra Bio shares in Q4 2016, an estimated $16.5K.
Kyntra Bio made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #1715 holding.
BlackRock Investment Management first reported a position in Kyntra Bio in Q4 2014 and has held it in 9 quarters since.
BlackRock Investment Management's Kyntra Bio position peaked at $4.89M in Q4 2015.
140 funds tracked by Wall St. Rank held Kyntra Bio as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.